Dr. Joseph Tucker headshot

Dr. Joseph Tucker discusses the potential of psychedelic-derived medicines

Mario Toneguzzi |

Dr. Joseph Tucker is President and CEO of MagicMed Industries Inc., a biotechnology company founded in 2020. The company is focused on creating a library of novel derivative molecules based on classic psychedelics such as psilocybin, N,N-dimethyltryptamine (DMT), mescaline, ibogaine, MDMA and LSD. MagicMed’s molecular derivatives library, the Psybrary™️, is intended to be an essential building block from which industry partners can develop new patented products. MagicMed’s mission is to unlock the full potential of psychedelic-derived medicines. The company is focused on the discovery and development of novel drug candidates, structurally related to classic psychedelics but with improved pharmaceutical characteristics.

Entrepreneurs are the backbone of Canada’s economy. To support Canada’s businesses, subscribe to our YouTube channel and follow us on FacebookInstagramLinkedIn and Twitter.

Want to stay up-to-date on the latest #entrepreneur podcasts and news? Subscribe to our bi-weekly newsletter

Related Podcasts

ALLPA is a hydroponic microgreen company with a focus on giving back

The three university students from three different countries serendipitously crossed paths while working part-time at a local hardware store....

Read More

How Dawn O’Connor built a virtual work community during a pandemic

Driven by a need to connect people in the throes of pandemic-life, Dawn O’Connor built a virtual community for...

Read More

How to grow in a connected digital ecosystem

Nikhil Sonpal is the Founder and CEO, of Mobility Quotient (MQ), a full-service digital agency, that provides business strategy,...

Read More

Join Our Newsletter

Subscribe to receive info on our latest news and episodes